{"id":"W2142329760","doi":"10.1111/bjd.12632","title":"Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":111,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Moncton Hospital","funders":"Celgene; Janssen Research and Development; Pfizer; Amgen","keywords":"Ustekinumab; Medicine; Psoriasis; Dermatology; Nail (fastener); Placebo; Dosing; Psoriasis Area and Severity Index; Randomized controlled trial; Nail disease; Surgery; Internal medicine; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067372,0.0004842502,0.0009637571,0.0001968347,0.0002321776,0.0004326942,0.0003612336,0.0004352393,0.003475571],"category_scores_gemma":[0.0009919651,0.0001790266,0.001002008,0.0002171035,0.0002515856,0.0002579184,0.0002076523,0.0009293986,0.0003346038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003622863,"about_ca_system_score_gemma":0.0004571455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005188675,"about_ca_topic_score_gemma":0.001527573,"domain_scores_codex":[0.9995362,0.0002502881,0.00003886398,0.00004890126,0.00007384046,0.00005196222],"domain_scores_gemma":[0.9993579,0.0002116698,0.0001611142,0.00003931842,0.00006304841,0.0001671022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5325571,0.02024467,0.02282766,0.003425875,0.003516947,0.0002280735,0.0002169171,0.0009527924,0.02981546,0.0002012469,0.006895626,0.3791176],"study_design_scores_gemma":[0.4557592,0.337777,0.1826912,0.0006196509,0.003960821,0.0009993403,0.00009348127,0.0009938719,0.007915043,0.0002348794,0.008912404,0.00004308622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751497,0.01879566,0.0002117905,0.0007449816,0.00009091542,0.0009524159,0.0004849687,0.00004235612,0.003527225],"genre_scores_gemma":[0.9866911,0.008673599,0.0006962105,0.000952118,0.0001939186,0.0003720747,0.0007401664,0.00000873002,0.001672063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003475571,"threshold_uncertainty_score":0.01162696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006298647247534306,"score_gpt":0.189572861714017,"score_spread":0.1832742144664827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}